BlackRock Inc. lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 1.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,392,338 shares of the medical research company’s stock after purchasing an additional 273,119 shares during the period. BlackRock Inc. owned 7.28% of Agilent Technologies worth $1,387,400,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Jennison Associates LLC bought a new stake in Agilent Technologies in the second quarter worth about $212,000. Skandinaviska Enskilda Banken AB publ raised its position in Agilent Technologies by 5.7% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 64,834 shares of the medical research company’s stock worth $3,428,000 after acquiring an additional 3,489 shares during the period. Commerce Bank bought a new stake in Agilent Technologies in the second quarter worth about $1,242,000. Delta Lloyd Asset Management N.V. bought a new stake in Agilent Technologies in the second quarter worth about $2,026,000. Finally, Cipher Capital LP raised its position in Agilent Technologies by 18.1% in the second quarter. Cipher Capital LP now owns 89,523 shares of the medical research company’s stock worth $5,309,000 after acquiring an additional 13,703 shares during the period.
In other Agilent Technologies news, CFO Didier Hirsch sold 1,200 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $66.00, for a total transaction of $79,200.00. Following the sale, the chief financial officer now owns 164,202 shares in the company, valued at approximately $10,837,332. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Michael R. Mcmullen sold 16,492 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $65.33, for a total transaction of $1,077,422.36. Following the sale, the chief executive officer now owns 211,872 shares in the company, valued at approximately $13,841,597.76. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 155,165 shares of company stock worth $9,768,409.
Several brokerages have commented on A. Wells Fargo & Company raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $42.92 to $60.73 in a research report on Wednesday, July 12th. BidaskClub raised shares of Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 11th. Deutsche Bank AG set a $68.00 price target on shares of Agilent Technologies and gave the company a “buy” rating in a research report on Wednesday, August 16th. Robert W. Baird boosted their price target on shares of Agilent Technologies from $57.00 to $62.00 and gave the company an “outperform” rating in a research report on Wednesday, May 24th. Finally, J P Morgan Chase & Co reissued an “overweight” rating and issued a $70.00 price target on shares of Agilent Technologies in a research report on Wednesday, August 16th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $63.91.
Agilent Technologies, Inc. (NYSE:A) opened at 65.96 on Friday. Agilent Technologies, Inc. has a 52 week low of $42.92 and a 52 week high of $66.42. The stock has a market cap of $21.23 billion, a PE ratio of 34.02 and a beta of 1.30. The company’s 50-day moving average is $62.40 and its 200 day moving average is $58.01.
Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The company had revenue of $1.11 billion for the quarter, compared to analysts’ expectations of $1.09 billion. During the same quarter last year, the business earned $0.49 EPS. The firm’s revenue was up 6.7% compared to the same quarter last year. On average, analysts expect that Agilent Technologies, Inc. will post $2.32 earnings per share for the current fiscal year.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.